Buscar
Resultados de la búsqueda
- Estudio para evaluar la preferencia de los pacientes y la satisfacción de la administración subcutánea de la combinación de dosis fija de Pertuzumab y Trastuzumab en participantes con cáncer de mama temprano positivo a HER2
-
... randomised multicentre, open-label, phase 2 trial. Lancet Oncology 2012;13(1):25-32. Gianni L, Pienkowski T, Im YH et al. 5-Year ... BO, Aft R et al. NCCN clinical practice guidelines in oncology (NCCN Guidelines®). Breast Cancer. Version I.2018 [internet]. ...
Ensayos Clínicos - ROCHE - 18/08/2021 - 6:58pm
- Estudio para describir el diagnóstico, el tratamiento contra el cáncer y el resultado clínico en pacientes con cáncer de mama recién diagnosticado en América Latina
-
... Latin American Cooperative Oncology Group (LACOG) Promotor ... Latin American Cooperative Oncology Group (LACOG) Participación del ...
Ensayos Clínicos - ROCHE - 18/08/2021 - 6:47pm
- A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer
-
... Medical Doctor, Second degree specialist in oncology Affiliation: ... Havana, National Institute of Oncology and Radiobiology (INOR), Dr. Elías Gracia Medina, Medical Doctor, ...
Clinical Trials - ROCHE - 18/08/2021 - 6:13pm
- A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America
-
... Latin American Cooperative Oncology Group (LACOG) Primary ... Latin American Cooperative Oncology Group (LACOG) Source(s) of monetary ...
Clinical Trials - ROCHE - 18/08/2021 - 6:07pm
- NAcGM3/VSSP/Montanide ISA 51 formulation in HIV, phase II.
-
... First Degree Specialist in Oncology Affiliation: ... First Degree Specialist in Oncology Affiliation: ...
Clinical Trials - CIM - 19/04/2021 - 3:41pm
- VSSP in renal cell carcinoma
-
... First grade specialist in Oncology Affiliation: ...
Clinical Trials - CIM - 08/04/2021 - 4:19pm
- Inmunoterapia con la combinación de NGcGM3/VSSP y nimotuzumab en pacientes con cáncer avanzado de pulmón de células no pequeñas (CPCNP)
-
... NGcGM3. 7. Estado general según el Eastern Cooperative Oncology Group (ECOG) menor igual 2. 8. Pacientes con expectativa de vida de ... 1995;14:350. 9. NCCN Clinical Practice Guidelines in Oncology. NSCLC. Version I.2013 www.nccn.org 10. Thongprasert S, Sanguanmitra ...
Ensayos Clínicos - CIM - 21/12/2020 - 11:38am
- Combined NGcGM3/VSSP and Nimotuzumab in advanced non-small cell lung cancer (NSCLC)
-
... Havana, “National Institute of Oncology and Radiobiology". Yoanna Ivette Flores Vega, MD. First degree specialist in Oncology Research ethics committees: ...
Clinical Trials - CIM - 21/12/2020 - 11:38am
- Oncoxin-Viusid/Stomach and gastric esophagus union cancer / Adults / Phase II
-
... First degree specialist in Oncology Affiliation: National Institute of Oncology and Radiobiology Postal ...
Clinical Trials - CATALYSIS - 21/12/2020 - 11:37am
- Oncoxin-Viusid/Cáncer de estómago y unión esófago gástrica/Adultos/Fase II
-
... J. Role of antioxidant complements and supplements in oncology in addition to an equilibrate regimen: a systematic review. Bull ... metastatic progression of colorectal cancer to the liver. Oncology letters 2017;13:4002-4012. Hernández-García S, González V, Sanz ...
Ensayos Clínicos - CATALYSIS - 21/12/2020 - 11:37am